Notice of Meeting, 9631-9632 [2022-03616]

Download as PDF Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices Dated: February 15, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2022–03667 Filed 2–18–22; 8:45 am] National Institute on Minority Health and Health Disparities; Notice of Closed Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Secondary Data Analysis Applications (R21). Date: March 28, 2022. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ashley Fortress, Ph.D., Designated Federal Official, Division of Extramural Activities, National Eye Institute, National Institutes of Health, 6700B Rockledge Drive, Ste. 3400, Bethesda, MD 20892, (301) 451–2020, ashley.fortress@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: February 15, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. lotter on DSK11XQN23PROD with NOTICES1 [FR Doc. 2022–03668 Filed 2–18–22; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 19:42 Feb 18, 2022 Jkt 256001 National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; HIV Health Disparity Research in Primary Care Settings. Date: March 30, 2022. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Gateway Plaza, 7201 Wisconsin Ave., Bethesda, MD 20817 (Virtual Meeting). Contact Person: Xinli Nan, M.D., Ph.D., Scientific Review Officer, Division of Scientific Programs, National Institute on Minority Health and Health Disparities, National Institutes of Health, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–594–7784, Xinli.Nan@ nih.gov. Dated: February 16, 2022. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–03665 Filed 2–18–22; 8:45 am] BILLING CODE 4140–01–P 9631 the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; URGenT: Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders. Date: March 9, 2022. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: Mirela Milescu, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/NIH NSC, 6001 Executive Boulevard, Suite 3208, MSC 9529, Bethesda, MD 20892, mirela.milescu@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: February 15, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–03666 Filed 2–18–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will convene via web conference on March 9, 2022, from 10:00 a.m. ET to 1:00 p.m. ET. The board will meet in open-session on March 9, 2022, from 10:00 a.m. ET to 1:00 p.m. ET, to discuss the Mandatory Guidelines for Federal Workplace Drug Testing Programs with updates from the Department of Transportation, the Nuclear Regulatory Commission and the Food and Drug E:\FR\FM\22FEN1.SGM 22FEN1 9632 Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices Administration. Other discussion topics include a presentation on the Drug-Free Workplace Program Summit meeting scheduled for May, 2022, NLCP drug testing results, and synthetic urines and adulteration. Meeting registration information can be completed at http://snacregister. samhsa.gov/MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https:// www.samhsa.gov/about-us/advisorycouncils/meetings or by contacting the Designated Federal Officer, Lisa S. Davis, M.S. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: March 9, 2022, from 10:00 a.m. to 1:00 p.m.: OPEN. Place: Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone: (240) 276–1440, Email: Lisa.Davis@ samhsa.hhs.gov. Anastasia Marie Donovan, Public Health Advisor, Division of Workplace Programs. [FR Doc. 2022–03616 Filed 2–18–22; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2022–0105] Cooperative Research and Development Agreement—Evaluation of Teledyne FLIR SF280HDEP Coast Guard, DHS. Notice of intent; request for comments. AGENCY: ACTION: The Coast Guard announces its intent to enter into a cooperative research and development agreement (CRADA) to evaluate and potentially modify target classification technology used in conjunction with electrooptical/infra-red (E.O./IR) systems. The Coast Guard is currently considering partnering with Teledyne FLIR, Inc. and solicits public comment on the possible participation of other parties in the proposed CRADA, and the nature of that lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:42 Feb 18, 2022 Jkt 256001 participation. The Coast Guard also invites other potential non-Federal participants, who have the interest and capability to bring similar contributions to this type of research, to consider submitting proposals for consideration in similar CRADAs. DATES: Comments must reach the Coast Guard on or before March 24, 2022. Synopses of proposals regarding future CRADAs must also reach the Coast Guard on or before March 24, 2022 ADDRESSES: Submit comments online at http://www.regulations.gov following website instructions. Submit synopses of proposals regarding future CRADAs to Mr. Jay Carey at his address listed in the FOR FURTHER INFORMATION CONTACT section. FOR FURTHER INFORMATION CONTACT: If you have questions on this notice or wish to submit proposals for future CRADAs, contact Mr. Jay Carey, Project Official, Aviation Branch, U.S. Coast Guard Research and Development Center, 1 Chelsea Street, New London, CT 06320, telephone 860–271–2600, email RDC-info@uscg.mil. SUPPLEMENTARY INFORMATION: Public Participation and Request for Comments We request public comments on this notice. Although we do not plan to publish responses to comments in the Federal Register, we will respond directly to commenters and may modify our proposal in light of comments. Comments should be marked with docket number USCG–2022–0105 and should provide a reason for each suggestion or recommendation. You should provide personal contact information so that we can contact you if we have questions regarding your comments; but please note that all comments will be posted to the online docket without change and that any personal information you include can be searchable online. For more about privacy and the docket, visit http:// www.regulations.gov/privacyNotice. We do accept anonymous comments. We encourage you to submit comments through the Federal Portal at http://www.regulations.gov. If your material cannot be submitted using http://www.regulations.gov, contact the Coast Guard (see FOR FURTHER INFORMATION CONTACT). Documents mentioned in this notice and all public comments, will be in our online docket at http://www.regulations.gov and can be viewed by following that website’s instructions. Additionally, if you go to the online docket and sign up for email alerts, you will be notified when comments are posted. PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 Do not submit detailed proposals for future CRADAs to http:// www.regulations.gov. Instead, submit them directly to the Coast Guard (see FOR FURTHER INFORMATION CONTACT). Discussion CRADAs are authorized under 15 U.S.C. 3710(a).1 A CRADA promotes the transfer of technology to the private sector for commercial use, as well as specified research or development efforts that are consistent with the mission of the Federal parties to the CRADA. The Federal party or parties agree with one or more non-Federal parties to share research resources, but the Federal party does not contribute funding. CRADAs are not procurement contracts. Care is taken to ensure that CRADAs are not used to circumvent the contracting process. CRADAs have a specific purpose and should not be confused with procurement contracts, grants, and other type of agreements. Under the proposed CRADA, the Coast Guard’s Research and Development Center (R&DC) will collaborate with one or more nonFederal participants. Together, the R&DC and the non-Federal participants will identify the capabilities, benefits, risks, and technical limitations of enhancing the SF280HD–EP to operate in support of USCG missions. We anticipate that the Coast Guard’s contributions under the proposed CRADA will include the following: (1) In conjunction with the nonFederal participant(s), assist in developing the evaluation test plan to be executed under the CRADA; (2) Provide the small unmanned aircraft system (SUAS) test range, test range support, facilities, and all approvals required for SUAS operation under the CRADA; (3) Provide airborne targets, operators, and associated equipment necessary to conduct the evaluation test plan; (4) Coordinate and receive any Unmanned Flight Clearance (UFC) for the evaluations to be executed under this CRADA, as required, to include: Privacy Threshold Analysis, Privacy Impact Assessment, Spectrum Approval with the Office of Information Assurance and Spectrum Policy (CG– 65), the Federal Communications Commission (FCC), the National Telecommunications and Information Administration (NTIA) Local Range 1 The statute confers this authority on the head of each Federal agency. The Secretary of DHS’s authority is delegated to the Coast Guard and other DHS organizational elements by DHS Delegation No. 0160.1, para. II.B.34. E:\FR\FM\22FEN1.SGM 22FEN1

Agencies

[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Pages 9631-9632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03616]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on March 9, 2022, from 
10:00 a.m. ET to 1:00 p.m. ET.
    The board will meet in open-session on March 9, 2022, from 10:00 
a.m. ET to 1:00 p.m. ET, to discuss the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs with updates from the 
Department of Transportation, the Nuclear Regulatory Commission and the 
Food and Drug

[[Page 9632]]

Administration. Other discussion topics include a presentation on the 
Drug-Free Workplace Program Summit meeting scheduled for May, 2022, 
NLCP drug testing results, and synthetic urines and adulteration.
    Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Lisa S. Davis, M.S.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: March 9, 2022, from 10:00 a.m. to 1:00 p.m.: OPEN.
    Place: Substance Abuse and Mental Health Services Administration, 
5600 Fishers Lane, Rockville, MD 20857.
    Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for 
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland 
20857, Telephone: (240) 276-1440, Email: [email protected].

Anastasia Marie Donovan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2022-03616 Filed 2-18-22; 8:45 am]
BILLING CODE 4162-20-P